LAD1 and gastric cancer: Our in vitro and in vivo studies, which are comparable to those on breast and colorectal malignancies [8, 10] provide additional evidence that LAD1 increases cellular invasion and migration, chemoresistance, tumor growth, and lung metastasis in GC.